Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule ...

Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...

Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.

Everseen today introduced Everseen Vision Agents, an AI innovation to optimize and transform business processes, creating the potential for unprecedented value for global retailers and other ...

Docking Drawer's Unwavering Dedication to Safety "At Docking Drawer, we're not just creating products; we're setting new standards for safety and functionality."When it comes to safety, no one in the ...

Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs ...

Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on Kymera Therapeutics (KYMR – Research Report) yesterday and set a price target ...

Cannabichromene (CBC), a lesser-known cannabinoid found in marijuana, may offer therapeutic benefits for inflammatory skin ...

Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...

Artificial intelligence (AI)-based models developed by a team of international researchers were able to identify ovarian ...